raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:140941

Short stature due to primary acid-labile subunit deficiency

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Infancy, Neonatal
Status
active

A rare growth hormone insensitivity syndrome characterized by moderate postnatal growth delay, markedly low circulating levels of insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 3 (IGFBP-3), normal response to growth hormone stimulation test, and insulin insensitivity marked by normal glucose levels and hyperinsulinemia. Additional findings may include subnormal IGF-2, IGFBP-1 and IGFBP-2 levels, as well as microcephaly, delayed puberty and bone maturation, and reduced bone mineral density in some cases.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enShort stature due to primary acid-labile subunit deficiency
frPetite taille par déficit primaire en sous-unité acide labile
deKleinwuchs durch primären Mangel der säurelabilen Untereinheit
esTalla baja por deficiencia primaria de subunidad ácido-lábil
itBassa statura da deficit primitivo della subunità acido-labile
nlKleine gestalte door primaire deficiëntie van zuurlabiele subeenheid
ptBaixa estatura por deficiência primária da subunidade ácido-lábil
plNiski wzrost z powodu niedoboru pierwotnej labilnej kwasowo podjednostki
csMalý vzrůst způsobený primárním deficitem acido-labilní podjednotky
ukНизькорослість через дефіцит первинної кислотолабільної субодиниці
zh原发性酸不稳定亚单位缺乏所致矮小
trPrimer aside dayanıksız alt birim eksikliği kaynaklı kısa boy

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM615961Evalidated
ICD-10E34.3NTBTattributedvalidated
ICD-115A61.0NTBTindexvalidated
MONDO0014420Evalidated
UMLSC4303612Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
IGFALSDisease-causing germline mutation(s) inAssessedHGNC:5468ENSG0000009976960148916p13.3insulin like growth factor binding protein acid labile subunit21396577[PMID]
5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Point prevalence<1 / 1 000 000—EuropeClass onlyNot yet validatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

11 annotations · validated 2026-05-26
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0001510Growth delay
HP:0008855Moderate postnatal growth retardation
HP:0045046Reduced insulin like growth factor binding protein acid labile subunit concentration
HP:0004322Short stature
Frequent (79-30%)
HP:0030353Decreased serum insulin-like growth factor 1
HP:0000823Delayed puberty
HP:0008189Insulin insensitivity
Occasional (29-5%)
HP:0040195Decreased head circumference
HP:0004349Reduced bone mineral density
HP:6000404Reduced circulating insulin-like growth factor 2 concentration
Excluded (0%)
HP:0034323Reduced circulating growth hormone concentration

Run the differential on the 4 obligate / very frequent terms

Annotation source: 20389102[PMID]_19729943[PMID]_21396577[PMID]_28737870[PMID]_39475135[PMID]_17726072[PMID]_14762184[PMID]

7

Sources for this card